-
曲金剛胺
- names:
Tromantadine
- CAS號:
53783-83-8
MDL Number: MFCD00869480 - MF(分子式): C16H28N2O2 MW(分子量): 280.41
- EINECS:258-770-0 Reaxys Number:
- Pubchem ID:64377 Brand:BIOFOUNT
曲金剛胺(53783-83-8,Tromantadine)是Amantadine衍生物,具有抗皰疹活性,曲金剛胺可抑制單純皰疹病毒1型(HSV-1)和HSV-2的復(fù)制。
| 貨品編碼 | 規(guī)格 | 純度 | 價格 (¥) | 現(xiàn)價(¥) | 特價(¥) | 庫存描述 | 數(shù)量 | 總計 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000720-5mg | 5mg | >99.0% | ¥ 5062.00 | ¥ 5062.00 | Backorder | ¥ 0.00 | ||
| YZM000720-1mg | 1mg | >99.0% | ¥ 1950.00 | ¥ 1950.00 | 2-3天 | ¥ 0.00 |
- 大包裝詢價 提供各種包裝,敬請垂詢
- 收藏商品 商品點(diǎn)評 加入購物車 立即購買
| 中文別名 | 曲金剛胺(53783-83-8);D 41;曲曼他定;N-(1-金剛烷基)-2-(2-二甲基氨基乙氧基)乙酰胺;姜黃素;曲曼他定'鹽酸金剛烷胺;一水合鹽酸金剛烷胺,一水合物;甘露定;維魯·梅爾茲;維魯·梅爾茲·塞羅爾;塞魯爾; |
| 英文別名 | Tromantadine(53783-83-8);D 41;N-(1-adamantyl)-2-(2-dimethylaminoethoxy)acetamide;tromantadin;tromantadine;tromantadine monohydrochloride;tromantadine monohydrochloride, monohydrate;tromantidine;Viru-Merz;Viru-Merz serol;Viru-Serol; |
| CAS號 | 53783-83-8 |
| Inchi | InChI=1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19) |
| InchiKey | UXQDWARBDDDTKG-UHFFFAOYSA-N |
| 分子式 Formula | C16H28N2O2 |
| 分子量 Molecular Weight | 280.41 |
| 溶解度Solubility | |
| 性狀 | Solid |
| 儲藏條件 Storage conditions | 存放在陰涼干燥處Pure form -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
曲金剛胺(53783-83-8,Tromantadine)實(shí)驗注意事項:
1.實(shí)驗前需戴好防護(hù)眼鏡,穿戴防護(hù)服和口罩,佩戴手套,避免與皮膚接觸。
2.實(shí)驗過程中如遇到有毒或者刺激性物質(zhì)及有害物質(zhì)產(chǎn)生,必要時實(shí)驗操作需要手套箱內(nèi)完成以免對實(shí)驗人員造成傷害
3.實(shí)驗后產(chǎn)生的廢棄物需分類存儲,并交于專業(yè)生物廢氣物處理公司處理,以免造成環(huán)境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
Tags:曲金剛胺試劑,曲金剛胺雜質(zhì),曲金剛胺中間體,曲金剛胺密度,曲金剛胺熔點(diǎn),曲金剛胺閃點(diǎn),曲金剛胺合成,曲金剛胺結(jié)構(gòu)式,曲金剛胺購買,曲金剛胺MSDS,
| 產(chǎn)品說明 | 曲金剛胺(53783-83-8,Tromantadine)是一種有效的單純皰疹病毒 (HSV) 的抑制劑 |
| Introduction | 曲金剛胺(53783-83-8,Tromantadine) is a herpes simplex virus (HSV) inhibitor. |
| Application1 | 曲金剛胺是具有抗皰疹活性的金剛烷胺衍生物,可抑制單純皰疹病毒1型(HSV-1)和HSV-2復(fù)制 |
| Application2 | Tromantadine是一種局部抗皰疹藥物,對單純皰疹病毒1型(HSV-1)復(fù)制具有兩個獨(dú)立的作用:早期,在病毒結(jié)合或穿透過程中,晚期,在DNA合成開始后。 |
| Application3 |
曲金剛胺(53783-83-8,Tromantadine)藥理學(xué):
1、曲金剛胺是一種環(huán)狀胺,具有抗單純皰疹病毒的活性。Tromantadine抑制病毒體吸收到細(xì)胞表面,以及病毒的滲透和脫膜。 Tromantadine在捷克共和國的市場名為Viru-Merz。曲金剛胺是一種抗病毒藥,用于治療帶狀皰疹和單純性皰疹。
2、曲金剛胺是抗病毒劑,曲金剛胺用于預(yù)防或治療病毒性疾病的藥物。曲金剛胺可能發(fā)揮作用的方式包括通過抑制病毒DNA聚合酶來防止病毒復(fù)制。曲金剛胺與特定的細(xì)胞表面受體結(jié)合并抑制病毒滲透或脫殼;抑制病毒蛋白質(zhì)合成;或阻止病毒組裝的后期。
| 警示圖 | |
| 危險性 | warning |
| 危險性警示 | Not available |
| 安全聲明 | H303吞入可能有害+H313皮膚接觸可能有害+H2413吸入可能對身體有害 |
| 安全防護(hù) | P264處理后徹底清洗+P280戴防護(hù)手套/穿防護(hù)服/戴防護(hù)眼罩/戴防護(hù)面具+P305如果進(jìn)入眼睛+P351用水小心沖洗幾分鐘+P338取出隱形眼鏡(如果有)并且易于操作,繼續(xù)沖洗+P337如果眼睛刺激持續(xù)+P2393獲得醫(yī)療建議/護(hù)理 |
| 備注 | 實(shí)驗過程中防止吸入、食入,做好安全防護(hù) |
| Rosenthal KS, et al. Tromantadine: inhibitor of early and late events in herpes simplex virus replication. Antimicrob Agents Chemother. 1982 Dec;22(6):1031-6. |
| Cheetham JJ, et al. Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranes. Biosci Rep. 1987 Mar;7(3):225-30. |
| Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranes Bioscience Reports 1987 |
| Tromantadine Reactions Weekly 2018 |
| Aciclovir and tromantadine have comparable efficacy InPharma 1989 |
曲金剛胺(53783-83-8,Tromantadine)參考文獻(xiàn):
1.Separation methods for tricyclic antiviral drugs.
Suckow RF1. J Chromatogr B Biomed Sci Appl. 2001 Nov 25;764(1-2):313-25.
A review of the published analytical methodology for the tricyclic antiviral (TAV) drugs is presented. While amantadine and rimantadine are the only two approved drugs for the prophylaxis and treatment of the influenza A virus, amantadine has also been approved for the treatment of Parkinson's disease. In addition, a few structurally related compounds are finding important clinical applications in other central nervous system-related disorders. To effectively evaluate the pharmacokinetics, biotransformations, stability, and other critical parameters that are necessary for pre-clinical and clinical studies, analytical methodology that conforms to the rigors of regulatory requirements must be developed and made available. This review discusses the analytical methods used in the determination of amantadine, rimantadine, tromantadine and memantine and the pre-clinical and clinical application of these techniques.
2.Topical tromantadine in the treatment of genital herpes. A double-blind placebo controlled study.
Petersen CS1, Weismann K, Avnstorp C, Rasmussen LP, Fogh H, Tikjøb G. Dan Med Bull. 1993 Sep;40(4):506-7.
A randomised double-blind placebo controlled trial was performed to assess the efficacy and safety of tromantadine ointment 1% in male patients with genital herpes. 45 patients with penile genital herpes of less than three days duration were randomised to local treatment with tromantadine ointment 1% or placebo (ointment base alone) five times daily up to 12 days. No difference in time of healing could be detected between the two groups (p = 1.0). Both the objective signs (vesicles, pustules, ulceration, and glandular swelling) and the subjective symptoms (itching, burning, pain and dysuria) all diminished simultaneously in the two groups.
3.Allergic contact dermatitis from tromantadine.
Jáuregui I1, Urrutia I, Gamboa PM, Antépara I. J Investig Allergol Clin Immunol. 1997 Jul-Aug;7(4):260-1.
Tromantadine is a topical antiviral agent derived from amantadine. In previous reports, 5% of treated patients developed contact allergy. We report the case of a 28-year-old woman who had a sudden worsening of a lip herpes after treatment with a tromantadine ointment, with strong positive patch testing to this substance. The purpose of this paper is to call attention to the fact that tromantadine is still widely used in several European countries as a second-line therapy for lip herpes, and therefore, new cases of sensitization to tromantadine are likely to occur.
- 相關(guān)產(chǎn)品
-
< >
- 推薦產(chǎn)品
-
< >
- 最新產(chǎn)品
-
< >
新聞
胞爬片免疫組化染色.png)
怎么做細(xì)胞爬片免疫組化染色實(shí)驗
細(xì)胞爬片免疫組化染色,是通過細(xì)胞爬片是讓玻片浸在細(xì)胞培養(yǎng)基內(nèi),細(xì)胞在玻片上生長,主要用于組織學(xué),免疫組織化學(xué)...
2020/7/20 22:04:33

提取病毒RNA的實(shí)驗方法
提取病毒RNA方法分別有:異硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26

9月開學(xué)季——助研新學(xué)期 范德送好禮
2025/8/28 15:30:55

Waxfilm 實(shí)驗室封口膜:技術(shù)與國際市場的雙重突破
在實(shí)驗室耗材領(lǐng)域,封口膜是保障實(shí)驗準(zhǔn)確性與穩(wěn)定性的關(guān)鍵產(chǎn)品之一。近年來,Waxfilm?實(shí)驗室封口膜憑借其卓...
2025/5/13 13:03:40

Waxfilm實(shí)驗室封口膜的5大突破
Waxfilm實(shí)驗室封口膜作為生物功能膜領(lǐng)域的國產(chǎn)技術(shù)突破和品牌突破,是生物領(lǐng)域中國技術(shù)發(fā)展的縮影。
2025/5/6 17:02:07

各種微流控芯片鍵合方法的優(yōu)缺點(diǎn)
微流控芯片鍵合:目前主要有激光焊接、熱壓鍵合、膠鍵合、超音波焊接,每種方法都有各自的優(yōu)缺點(diǎn)。本文主要介紹聚酯...
2023/7/28 10:43:09

新一代微流控鍵合解決方案
微流控鍵合解決方案:微流控芯片制造的一個重要環(huán)節(jié),也是最容易被忽視的--芯片鍵合。其中一個重要因素是:微流控...
2023/7/27 12:44:28
驗動物圖.png)
熒光素鉀鹽使用說明
D-熒光素鉀鹽(K+)設(shè)計用于體外和體內(nèi)生物發(fā)光測定。D-熒光素的質(zhì)量和純度對于獲得良好和可重復(fù)的結(jié)果至關(guān)重...
2023/7/20 11:05:11

如何選BSA(牛血清白蛋白)
如何選BSA(牛血清白蛋白):牛血清白蛋白(BSA)有多種形式,如何選擇適合自己的牛血清白蛋白(BSA)是一...
2023/2/14 13:09:18

牛血清白蛋白(BSA)常見問題
牛血清白蛋白(BSA)常見問題:牛血清白蛋白(BSA)在實(shí)驗室中是通用的,可用于蛋白質(zhì)印跡、細(xì)胞組織培養(yǎng)、P...
2022/10/19 9:39:51



購物車 


